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ABSTRACT
The effects of chloroform extract of Tripterygium wil-
fordii Hook f (TWH extract) on eosinophilia and IgE
hyperproduction induced by Mesocestoides cortii
infection were examined in BALB/c mice. Mice were
infected with M. cortii by intraperitoneal injection of
500 tetrathyridia. The number of peripheral blood
eosinophils and IgE levels were examined 21 days
after infection. Oral administration of TWH extract
once per day for three weeks dose-dependently sup-
pressed peripheral blood eosinophilia and serum IgE
levels, which are enhanced by M. cortii infection.
Significant suppression of both eosinophilia and
serum IgE levels were first noted in mice treated with
300 m g/kg of the extract. The maximum inhibition was
observed when mice were treated with 410 m g/kg
TWH extract. The ability of spleen cells to produce
interleukin (IL)-4 and IL-5 in response to M. cortii
somatic antigen was also significantly suppressed
when donor mice were treated with more than 
400 m g/kg of the extract. Extraxct treatment at a daily
dose of 400 m g/kg suppressed costimulatory molecule
(CD40 and CD86) expression on spleen cells induced
by M. cortii infection. These results may suggest that
TWH extract will be a good candidate for immuno-
therapy in allergic diseases.
Key words: eosinophilia, immunoglobulin E, Meso-
cestoides cortii, mouse, suppression, Tripterygium 
wilfordii.
INTRODUCTION
The importance of inflammation in the pathogenesis 
of allergic diseases, such as bronchial asthma, atopic 
dermatitis and urticaria, has recently been stressed.1–3
Considerable progress has been made to determine the
effector mechanisms behind the allergic diseases and has
revealed that the development of the diseases is regu-
lated by a vast array of mediators. Generally, these may
be divided into two broad groups. Chemical mediators,
such as serotonin, histamine, leukotrienes and other
various chemotactic factors, may be primarily involved in
the early events of acute inflammatory reactions. A
second group of mediators, growth factors and inter-
leukins, which are the essential vectors in the cellular
communication system, may be involved in long-term
tissue alterations in the inflammatory diseases.3–5
Anti-allergic agents (e.g. sodium cromoglycate, aze-
lastine, terfenadine etc.) are effective in the treatment of
allergic disorders.1–5 These agents are thought to act at
least in part by stabilizing the cell membrane of effector
cells, such as mast cells and eosinophils, and by prevent-
ing release of chemical mediators from the cells.6 While
the treatment with these agents is reported to provide
symptomatic relief and to speed resolution of the early
phase of allergic responses, it fails to prevent or reverse
the inflammation, which can lead to irreversible tissue
damage. Emphasis is therefore now being placed on
more aggressive institution of anti-inflammatory therapy
in allergic diseases to prevent the tissue destruction
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caused by unmitigated inflammation.7,8 From this point of
view, immunosuppressive agents, such as cyclosporine A,
FK506 and spagualin, are recommended in the treat-
ment of the diseases and clinical trials have reported the
attenuating effects of these immunosuppressive agents
on clinical conditions of allergic diseases.7,8
Tripterygium wilfordii Hook f (TWH) is a traditional
Chinese herb grown in the south of China. Extract from
TWH, obtained either by chemical or by water-boiling
methods, has been widely used in the treatment of some
immune related diseases (e.g. rheumatoid arthritis,
Bechet’s disease, system lupus erythematosus etc.) and
satisfactory results have been obtained.9–11 In addition,
animal experiments have demonstrated that TWH extract
significantly inhibits mitogen-induced T cell proliferation,
mixed lymphocyte reaction and cytotoxic T cell activity.12–14
Although TWH extract is also reported to inhibit helper 
T-cell mediated immune responses15 and to prolong skin
allograft survival in mice,13 the therapeutic efficacy of the
extract on allergic disorders has not been reported.16
Infection with parasites, especially larval worm, is well
known to induce IgE hyperproduction and peripheral
blood eosinophilia in mammalian hosts, including
humans and rodents.17–19 Because these findings are
quite similar to those in allergic diseases,17–19 the 
parasite/host system may be considered to provide a
suitable model in which to examine the efficacy and the
mode of action of the agents on allergic diseases.20,21
Mesocestoides cortii is a common parasite in dogs, cats
and man in North and Central America. The preadult
worm of this cestoda parasite is called tetrathyridial larva
and occurs in the peritoneal cavity of wild rodents.
Infection of rodents with tetrathyridial larva is well
accepted to produce peripheral blood eosinophilia and
IgE hyperproduction.22 In the present study, we have
therefore used the M. cortii/mouse system and examined
the influence of TWH extract on peripheral blood
eosinophilia and IgE hyperproduction.
METHODS
Mice
Male BALB/c mice were purchased from Charles River
Japan Inc. (Atsugi, Japan). They were allowed at least 
1 week to adapt to the environment (25 ± 3°C, 55 ± 5%
humidity and a 12 h light/dark cycle) and were used at 
6 weeks of age.
Agent
T2 tablets, chloroform methanol extracts of TWH, were
purchased from Zhuzhou Pharmaceutical Co. (Zhuzhou,
Hunan, China) as an oral administration grade for
humans. Each T2 tablet contained 30.0 m g extract and
did not show the antihelminthic and parasitecidal activi-
ties in vivo.15 For administration into mice, randomly
selected tablets were ground and suspended in normal
saline at a concentration of 30.0 m g/mL.
Parasite and parasitologic technique
Mesocestoides cortii kindly donated by Dr A Niwa
(School of Medicine, Kinki University) was maintained 
in mice by intraperitoneal injection of 50 m L packed
tetrathyridia. For preparation of M. cortii somatic antigen,
tetrathyridia were washed out with phosphate-buffered
saline (PBS) from the peritoneal cavity of mice on day 30
after infection.22 Worms were washed 5 times with 
ice-cold PBS to remove unwanted materials, such as 
peritoneal leukocytes, and then disrupted with a sonic
dismembrator (Artek System Corp., Farmingdale, NY,
USA) at 60 W in an ice-cold water bath for 60 min. The
homogenate was centrifuged at 50 000 g for 60 min at
4°C and the supernatant obtained. After measuring its
protein concentration using the Bio-Rad Protein Assay Kit
(Bio-Rad Laboratories, Richmond, CA, USA), the prepa-
ration was sterilized by passing through a 0.22 m m filter
(Nihon Millipore Corp., Yonezawa, Japan) and stored at
– 40°C until use.15
Cell preparation
Spleens were removed from mice killed under ether
anesthesia. The organs prepared from five individual
mice were pressed through a 60 gauge steel mesh to
obtain single cell suspensions and washed once with PBS.
After lysing red blood cells with 0.15 mol/L NH4Cl-Tris
buffer, the cell suspension was filtered through a 200
gauge steel mesh to remove cell clumps and debris. The
cells were washed 4 times with RPMI-1640 medium
(Sigma Chemical Co., St Louis, MO, USA) supplemented
with 10% heat-inactivated fetal bovine serum (Flow
Laboratories, North Ryde, NSW, Australia) and the final
concentration of cells was adjusted to 5 · 106 cells/mL.
Cell culture and culture supernatants
A total of 5 · 106 cells was cultured in 24-well plates
(IWAKI GLASS Co. Ltd, Tokyo, Japan) in the presence or
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absence of 100 m g/mL specific antigen.15 Culture super-
natants used for cytokine assay were obtained 48 h after
incubation.
Cytokine assay
Interleukin (IL)-4 and IL-5 levels in culture supernatants
were assayed by mouse cytokine enzyme-linked immuno-
sorbent assay (ELISA) Test Kits (Genzyme Corp., Cam-
bridge, MA, USA). The ELISA were done in duplicate
according to the manufacturer’s recommendation and
the results were expressed as mean pg/mL ± SD of five
mice.
Assay for immunoglobulin E
Blood was obtained from retro-orbital plexus in a volume
of 50 m L. After clotting, the serum was obtained and the
total serum IgE levels were assayed by mouse IgE ELISA
Test Kits (Yamasa Co. Ltd, Chiba, Japan). The ELISA 
was done in duplicate according to the manufacturer’s
recommendation and the results were expressed as mean
ng/mL ± SD of five mice.
Eosinophil counts
Blood was smeared on microscope slides and stained
with Giemsa solution. A total of 300 nucleated cells was
counted and percentage of eosinophils calculated.
Flow cytometry
Spleen cells (1 · 106/mL) were first incubated for 5 min
at 4°C with 10.0 m g monoclonal antibody (mAb)
against mouse CD16 (rat IgG2b; Pharmingen, San
Diego, CA, USA) to block Fc g III/II receptors. After two
washes with PBS, the cells were incubated for another
25 min at 25 ± 2°C with 10.0 m g of either fluorescein
isothiocyanate (FITC)-conjugated rat antimouse CD40
(rat IgG2a; Pharmingen) or FITC-conjugated hamster
antimouse CD86 (hamster IgG; Pharmingen). After two
washes, the cells were resuspended in fresh PBS at a
concentration of 0.5 · 106 cells/mL and analyzed on 
a fluorescence-activated cell sorter (FACScan; Becton
Dickinson, Downers Grew, CA, USA). Dead cells were
gated out by means of forward scatter and sideward
scatter. Fluorescence of 104 cells was recorded and the
data were analyzed with Consort 30 software (Becton
Dickinson).
Statistical analyses
The significance of differences in mean values between
two groups was examined by the Mann–Whitney U-test.
RESULTS
Influence of Mesocestoides cortii infection on
eosinophilia and IgE hyperproduction
The present study was designed to examine whether 
M. cortii infection could affect the number of peripheral
blood eosinophils and IgE production. BALB/c mice were
infected with M. cortii by intraperitoneal injection of
various numbers of larvae. Counting the number of
peripheral blood eosinophils and examining IgE levels
were performed daily after infection. As shown in Fig. 1a,
infection of mice with M. cortii caused a gradual increase
in the number of peripheral blood eosinophils, peaked on
day 14 and plateaued thereafter. Likewise, the amount of
IgE in peripheral blood rose to a level more than 30-fold
that observed in non-infected control (approximately 
100 ng/mL; Fig. 1b) from day 14 of the infection on-
wards. The data in Fig. 1a,b also clearly show that there is
no apparent difference between these two immunologic
responses and number of worms used to infect.
Effect of TWH extract on eosinophilia and IgE
production
The present study was designed to examine the influence
of TWH extract on eosinophilia and IgE production.
BALB/c mice were infected with M. cortii by intraperi-
toneal injection of 500 M. cortii larvae on day 0. The
mice were treated orally with various concentrations of
TWH extract once per day for 21 days, starting on the day
of infection. Samples for examining the number of
eosinophils and IgE levels were obtained 21 days after
infection. The TWH extract inhibited an increase in
eosinophil numbers induced by M. cortii infection in a
dose-dependent manner. As the concentration of TWH
extract administered was increased, the number of eosin-
ophils decreased and complete inhibition, not significant
compared with the non-infected control (P > 0.05), was
observed when mice were treated with the extract at a
single dose of 410 m g/mL (Fig. 2). Although administra-
tion of TWH extract also dose-dependently suppressed IgE
hyperproduction, complete suppression, not significant
compared with the non-infected control (P > 0.05), was
first observed when the mice were treated with 400 m g/mL
TWH extract (Fig. 3).
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Fig. 1 Influence of Mesocestoides cortii infection on peripheral blood eosinophilia and serum IgE levels in mice. BALB/c mice
were infected with M. cortii by intraperitoneal injection of various numbers of tetrathyridia on day 0. Samples for examining number
of eosinophils and serum IgE levels were obtained as indicated. The results are expressed as the mean ± SD 
of five individual mice. (h), Non-infected control; (j), infected with 100 tetrathyridia; (d), infected with 500 tetrathyridia; 
(s), infected with 1000 tetrathyridia.
Fig. 2 Influence of Tripterygium wilfordii Hook f (TWH)
extract on peripheral blood eosinophilia. BALB/c mice were
infected with Mesocestoides cortii by intraperitoneal injection of
500 tetrathyridia on day 0 (j). (h), Non-infected. The mice
were treated orally with various doses of TWH extract once per
day for 21 days. The number of eosinophils was examined on
day 21 and the results were expressed as the mean (%) ± SD of
five individual mice. *P > 0.05 (not significant compared with
non-infected control).
Fig. 3 Influence of Tripterygium wilfordii Hook f (TWH)
extract on serum IgE hyperproduction. BALB/c mice were
infected with Mesocestoides cortii by intraperitoneal injection of
500 tetrathyridia on day 0 (j). (h), Non-infected. The mice
were treated orally with various doses of TWH extract once per
day for 21 days. Serum IgE level was examined on day 21 by
enzyme-linked immunosorbent assay and the results were
expressed as the mean (ng/mL) ± SD of five individual mice. 
*P > 0.05 (not significant compared with non-infected control).
Effects of TWH extract on IL-4 and IL-5 
production from spleen cells in response to
antigenic stimulation in vitro
Because IL-4 and IL-5 are well known to be essential
factors for IgE production and eosinophil growth,23,24
the present study was undertaken to examine whether
TWH extract suppresses the production of these cytokines
and results in inhibition of both IgE production and
eosinophilia. BALB/c mice were intraperitoneally infected
with 500 larvae on day 0. These mice were administered
orally with various doses of TWH extract once per day for
21 days, starting on the day of infection. Spleen cells were
prepared on day 21 and cultured in vitro in the presence
of M. cortii somatic antigen for 48 h. The culture super-
natants were obtained for examining the levels of IL-4 
and IL-5. As shown in Fig. 4a,b, treatment of mice with
100 m g/kg per day TWH extract did not affect the ability 
of spleen cells to produce IL-4 and IL-5 in response to
antigenic stimulation in vitro. However, administration of
TWH extract at a single dose of 200 m g/kg significantly
suppressed production of both IL-4 (P < 0.05) and IL-5 
(P < 0.01) and the minimum dose of TWH extract to
completely inhibit the production was 400 m g/kg per day
(Fig. 4a,b).
Effect of TWH extract on the expression of
costimulatory molecules on spleen cells
It is well known that costimulatory signals provided by the
interaction of T cell surface molecules with their ligands,
such as CD40 and CD86, expressed on antigen-presenting
cells (APC) are essential for successful activation of 
T cells. We therefore finally investigated whether TWH
extract can suppress costimulatory molecule expression
induced by M. cortii infection and result in inhibition of
the immune responses as stated earlier. BALB/c mice
were infected with 500 M. cortii larvae on day 0. These
mice were treated orally with 400 m g/kg per day TWH
extract for 21 days. On day 21 after infection, spleen
cells were obtained from three individual mice and exam-
ined for CD40 and CD86 expression. Administration of
TWH extract into non-infected mice scarcely affected
CD40 expression on spleen cells (Fig. 5a,b). However,
TWH extract caused suppression on CD40 expression
enhanced by M. cortii infection; the ratio (small and large
cells) of CD40-positive cells in infected and saline-
treated mice was reduced from 4 to 1 by treatment with
TWH extract (Fig. 5c,d). As shown in Fig. 6a,b, TWH
extract also produced no apparent effects on CD86
expression when the extract was administered into
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Fig. 4 Influence of Tripterygium wilfordii Hook f (TWH) extract on the ability of spleen cells to produce IL-4 (a) and IL-5 (b) in
response to antigenic stimulation in vitro. BALB/c mice were infected with Mesocestoides cortii by intraperitoneal injection of 500
tetrathyridia on day 0. The mice were administered orally with various doses of TWH extract once per day for 21 days. Spleen cells
were prepared from mice on day 21 and cultured in vitro with M. cortii somatic antigen. After 48 h, the culture supernatants were
obtained and cytokine concentrations were examined by enzyme-linked immunosorbent assay. The results were expressed as the
mean (pg/mL) ± SD of five individual mice. *P < 0.05, **P < 0.01.
non-infected mice and examined for the expression of
CD86 on spleen cells. In contrast, TWH extract showed
strong suppressive effects on CD86 expression induced
by M. cortii infection; the ratio (small and large cells) of
CD86-positive cells in infected and saline-treated mice
was reduced from 4 to 1 by treatment with TWH extract
(Fig. 6c,d).
DISCUSSION
A variety of preparations of a Chinese traditional medi-
cine, TWH extract, have been reported to have therapeutic
effects on autoimmune diseases, including rheumatoid
arthritis (RA), systemic lupus erythematosus and Bechet’s
diseases, among others.9–11 Because of the beneficial
clinical impact, many efforts have been made to under-
stand how these preparations exert their therapeutic
function. Results obtained from these studies have shown
that TWH is able to suppress inflammatory process
induced by a variety of stimuli.12–14,25 Recently, we have
reported that TWH extract can suppress the development
of the chronic graft-versus-host reaction (GVHR) induced
in (C57BL/6 · DBA/2) hybrid mice by injection of DBA/2
spleen cells.26 The early events in the chronic GVHR are
reported to contain similar mechanistic elements to those
seen in allergic responses characterized by elevating IgE
production,27,28 suggesting the efficacy of TWH extract in
the treatment of allergic responses associated with IgE
hyperproduction. However, there is no direct evidence
showing the protective activity of TWH extract in allergic
diseases. The experiments presented here characterize
the effects of TWH extract on allergic immune responses,
especially eosinophilia and IgE hyperproduction, during
normal in vivo immune responses and evaluate the possi-
bility of clinical use in the treatment and the management
of allergic diseases as an anti-allergic agent. The model
examined is that of eosinophilia and IgE hyperproduction
during M. cortii infection. In the present study, we exam-
ined first the influence of TWH extract on eosinophilia and
IgE hyperproduction. The data obtained clearly show that
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Fig. 5 Suppressive effect of
Tripterygium wilfordii Hook f
(TWH) extract on CD40 expres-
sion on spleen cells. BALB/c mice
were infected with Mesocestoides
cortii by intraperitoneal injection
of 500 tetrathyridia on day 0. The
mice were administered orally
with 400 m g/kg TWH extract
once per day for 21 days. Spleen
cells were prepared from mice on
day 21 and examined for CD40
expression by flow cytometry. The
numbers in each quadrant repre-
sent mean percentage ± SD of
CD40-positive cells of three
mice. (a) Non-infected, saline-
treated control; (b) non-infected,
TWH extract-treated control; 
(c) infected, saline-treated; (d)
infected, TWH extract-treated.
TWH extract can suppress these two immune responses
induced by M. cortii infection in dose-dependent manner:
although administration of TWH extract at a single dose 
of 100 m g/kg did not influence the M. cortii-induced
immune responses, treatment of mice with more than 
200 m g/kg extract caused significant suppression of the
responses. Complete suppression was observed when
mice were treated with the extract at a single dose of 
400 m g/kg for 3 weeks, which is one-fourth of the 
recommended therapeutic dose in human autoimmune
diseases, such as RA, systemic lupus erythematosus 
and psoriasis.8–10 The most striking feature of the histo-
pathology of allergic diseases is the intense infiltration
with eosinophils, macrophages and lymphocytes.29–31
Eosinophils can secrete a number of lipid mediators and
proteins, which may have a role to play in the patho-
physiology of the allergic diseases.30 The overproduction
of IgE is also generally recognized as a common feature
of the allergic diseases and the participation of this anti-
body in the diseases is well documented.29 From these
reports, the present results may suggest that TWH extract
is a good candidate for the agent in the treatment and
management of allergic diseases.
The TWH extract has been reported to suppress
immune responses through the inhibition of T cell func-
tion, especially cytokine secretion, and to have a slight
effect on B cell proliferation and antibody forma-
tion.15,32,33 Although experimental and clinical data
suggest that IgE synthesis in B cells is a complex process
involving several cellular and molecular interactions,
there is an established concept that IL-4 is the most
essential cytokine for the generation of IgE.23 Eosinophils
are granular cells that arise principally in the bone
marrow. Eosinophil differentiation, like that of all other
leukocytes, is influenced by several types of cytokines,
such as IL-3, IL-5 and granulocyte–macrophage colony
stimulating factor.30,31 Of these cytokines, IL-5 is
accepted to be specific for eosinophils and the most
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Fig. 6 Suppressive effect of
Tripterygium wilfordii Hook f
(TWH) extract on CD86 expres-
sion on spleen cells. BALB/c
mice were infected with Meso-
cestoides cortii by intraperitoneal
injection of 500 tetrathyridia on
day 0. The mice were adminis-
tered orally with 400 m g/kg
TWH extract once per day for 
21 days. Spleen cells were pre-
pared from mice on day 21 and
examined for CD86 expression
by flow cytometry. The numbers
in each quadrant represent
mean percentage ± SD of
CD86 positive cells of three
mice. (a) Non-infected, saline-
treated control; (b) non-infected,
TWH extract-treated control; 
(c) infected, saline-treated; (d)
infected, TWH extract-treated.
important cytokine for terminal differentiation of the
committed eosinophil precursors.24 It is also accepted that
IL-5 can lead to the specific recruitment of eosinophils,
enhanced eosinophil cytotoxicity and prolonged eosin-
ophil survival.24 My unpublished data (Asano, 1999)
shows no toxic effects of TWH extract on granulocytes,
such as mast cells and eosinophils, when these cells were
cultured in the presence of 10.0 m g/mL extract. Earlier
reports and our unpublished data may suggest that the
suppressive effects of TWH extract on eosinophilia and
IgE hyperproduction is owing to inhibitory action of TWH
extract on IL-4 and IL-5 production from T cells.25,26 This
suggestion may be supported by the observation that
TWH extract can suppress the ability of spleen cells to
produce IL-4 and IL-5 when the cells are prepared from
M. cortii infected and TWH extract-treated mice and cul-
tured in the presence of specific antigen. There is now
extensive evidence implicating allergen-specific type 2
helper T cells (Th2) as key orchestrators of the chronic
inflammatory responses that underlie many allergic dis-
eases.23,30 Optimal T cell activation requires not only
interaction between antigen peptide bound to MHC mol-
ecules of APC and the T cell receptor, but also additional
signals, termed costimulation.34 A number of recent
reports have shown that ligation of costimulatory mole-
cules, especially CD28 and CD86, is essential for Th2
cell activation and production of IL-4 and IL-5.35–37
Interaction between CD40 on B cells and CD40 ligand
(CD40L) on T cells has been also reported as an impor-
tant costimulatory signal required for switch recombination
to IgE synthesis in the presence of IL-4.38 These reports
prompted us to examine the influence of TWH extract on
costimulatory molecule expression. The present results
clearly show that TWH extract exerts suppressive effects
on CD40 and CD86 expression on APC in response to 
M. cortii infection, when mice were treated with TWH extract
at a daily dose of 400 m g/kg once per day for 3 weeks.
Although the present study clearly shows that treatment
of mice with TWH extract can suppress eosinophilia and
IgE hyperproduction through inhibition of both Th2 cell
cytokine production and costimulatory molecule expres-
sion on APC, the precise mechanisms by which TWH
extract can suppress cytokine production and the expres-
sion of cell surface molecules are not clear at present.
Further experiments are needed to clarify this point. A
number of compounds has been isolated from TWH
extract or cultured plant cell lines and structurally identi-
fied, but the active compounds of the extract has not been
completely delineated.14 Diterpenoid compounds, such
as tripchloride, triptolide and tripdiolide, have been iso-
lated from TWH and reportedly have anti-inflammatory
and immunosuppressive effects.39–41 It has also been
reported that the suppressive potential of triptolide is
slightly greater than that of tripdiolide and the combina-
tion of triptolide and tripdiolide at a 1:1 molar ratio
causes more inhibition of immune responses, including
cytokine production and lymphocyte proliferation in
vitro.14 From these reports, it may be suggested that the
immunosuppressive activity in M. cortii-infected mice is
brought about by the combination of both triptolide and
tripdiolide. Biochemical analysis of the constituents of
TWH extract will be important in further delineating its
mechanisms of action in allergic immune responses.
In conclusion, the findings of the present study demon-
strate that TWH extract can inhibit development of M.
cortii-induced immune responses, which are quite similar
to those of allergic diseases. Our previous reports15,26
show that TWH extract does not show adverse effects,
such as loss of appetite, ruffled fur and a hunched
posture, when mice are treated with the extract for more
than 3 weeks. The present results therefore may suggest
that the extract will be a useful drug in the treatment and
prevention of allergic diseases.
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